Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production platform, with Dyadic ...

In academic and industrial protein research, speed, accuracy, and accessibility are essential. After purifying proteins using ...

Rising demand for recombinant proteins, automation-ready cloning workflows, and AI-integrated molecular biology kits accelerates market growth at a CAGR of 10.68%.Austin, United States, March 25, 2026 ...

Since I stepped into the President’s role in June 2025, our focus has been very clear: to accelerate Dyadic International, Inc.’s transition from a development-stage platform company into a commercial ...

Cloud-Clone drives technological innovation for obesity research, providing validated targets for precise matching of ...

Commercial launch of AlbuFree DX recombinant human albumin by Proliant Health & Biologicals using Dyadic's production platform, with Dyadic eligible to receive a share of profits from product salesExp ...

Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.

Neion Bio’s Raptor™ platform utilizes cutting-edge genetic engineering to harness nature’s most efficient molecular factories ...

Learn how synthetic promoters bring innovation to gene expression, enhancing performance and safety in biotechnology ...

Hørsholm, Denmark, 25 March 2026 - ExpreS2ion Biotech Holding AB's affiliate ExpreS2ion Biotechnologies ApS ("ExpreS2ion"), a clinical-stage biotechnology company with a focused pipeline of active imm ...

Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.

BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.